Parkland Investor Presentation — May 2022

Document content

2022 First Quarter Results

Forward Looking Statement & Note on Specified Financial Measures

Certain statements contained herein constitute forward -looking information and statements (collectively, "forward -looking statements") .When used the words "expect", "will", "could", "would", "believe", "continue", "pursue" and

similar expressions areintended toidentify forward -looking statements .Inparticular, this presentation contains forward -looking statements with respect to,among other things :business strategies and objectives ;2022 Adjusted

EBITDA guidance ;Parkland's 2022 strategic initiatives tomeet our customers' evolving needs, including with respect tofocusing onorganic growth, integration and synergy capture, delivering cash flows, expanding OntheRun,

growing food capabilities, accelerating and growing digitally, increasing co-processing volumes and expanding bio-feedstocks, growing our renewable business and EVultra -fast charging ;;maintaining Parkland's strong

balance sheet ;and available liquidity under the Credit Facility .These statements involve known and unknown risks, uncertainties and other factors that may cause actual results orevents todiffer materially from those

anticipated insuch forward -looking statements .Noassurance can begiven that these expectations will prove tobecorrect and such forward -looking statements included inthis presentation should not beunduly relied upon .

These forward -looking statements speak only asofthe date ofthis presentation .Parkland does not undertake any obligations topublicly update orrevise any forward -looking statements except asrequired bysecurities law.

Actual results could differ materially from those anticipated inthese forward -looking statements asaresult ofnumerous risks and uncertainties including, but not limited to,general economic, market and business conditions,

including the duration and impact oftheCOVID -19pandemic ;Parkland's ability toexecute itsbusiness strategies and achieve itsgrowth ambitions, including without limitation, Parkland's ability toconsistently identify accretive

acquisition targets and successfully integrate them, successfully implement organic growth initiatives and tofinance such acquisitions and initiatives onreasonable terms ;industry capacity ;competitive action byother

companies ;refining and marketing margins ;the ability ofsuppliers tomeet commitments ;actions bygovernmental authorities and other regulators including but not limited toincreases intaxes orrestricted access tomarkets ;

changes and developments inenvironmental and other regulations ;and other factors, many ofwhich arebeyond the control ofParkland .See also the risks and uncertainties described in"Forward -Looking Information" and

"Risk Factors" included inParkland’s Revised Annual Information Form dated March 17,2022 ,and in"Forward -Looking Information" and "Risk Factors" inthe Management’s Discussion and Analysis dated May 4,2022 forthe